Ani Pharmaceuticals, Inc
N/MPrice / tangible book
Market cap
$1.60B
Tangible equity
-$1.28M
Price / tangible book
N/M
Price / book
2.96x
Return on equity
14.5%
Return on assets
5.4%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: ANIP stock price vs SPGI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SPGI's multiple
Needs SPGI P/E.
Implied fair value · at ANIP's multiple
Needs ANIP P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple discount
Multiple discount
Profitability edge
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: ANIP FY 2025 (ended Dec 31, 2025) · SPGI FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$1.60B
Tangible equity
-$1.28M
Price / tangible book
N/M
Price / book
2.96x
Return on equity
14.5%
Return on assets
5.4%
Efficiency ratio
—
Price / tangible book
Market cap
$131.28B
Tangible equity
-$21.62B
Price / tangible book
N/M
Price / book
4.22x
Return on equity
14.4%
Return on assets
7.3%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ANI PHARMACEUTICALS, INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
S&P Global Inc. · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.57x
0.44x
Net debt / EBITDA
Leverage against operating earnings
0.11x
1.61x
Cash and equivalents
Liquid reserves on the balance sheet
$285.59M
$1.80B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SUPERNUS PHARMACEUTICALS, INC.
ANIP vs SUPN
PERRIGO Co plc
ANIP vs PRGO
Viatris Inc
ANIP vs VTRS
Organon & Co.
ANIP vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
ANIP vs TEVA
Moody's Corporation
ANIP vs MCO
MSCI Inc.
ANIP vs MSCI
Verisk Analytics, Inc.
ANIP vs VRSK
Intercontinental Exchange, Inc.
ANIP vs ICE
$309.11M
$13.81B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.